About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Side effect(s) of Selegiline

Read the side effects of Selegiline as described in the medical literature. In case of any doubt consult your doctor or pharmacist.

Most Common- Dizziness, nausea, pain, headache, sleeplessness, runny nose, movement disorder, back pain, mouth ulcer, and indigestion.

Body as a Whole - Allergic reaction, inflammation of skin, face swelling, fever, bruising.

Central Nervous System - Lack of coordination, depression, dizziness, movement disorder, hallucinations, headache, sleeplessness, drowsiness, tremor, abnormal gait, agitation, emotional lability, increased salivation, nervousness, nerve pain, personality disorder, psychosis, vertigo, migraine.

Heart- High blood pressure, chest pain, abnormal heart rate and/or rhythm, stroke, congestive heart failure, heart arrest, low blood pressure, heart attack, pallor, syncope.

Gastrointestinal- Constipation, diarrhea, difficulty in swallowing, indigestion, flatulence, nausea, ulcer of mouth, esophagus or stomach, tooth disorder, vomiting, loss of appetite, gall stone, colitis, gum inflammation, hepatitis.

Blood- Bruising, abnormal platelet counts, anemia, increased level of white blood cells.

Metabolic- Low potassium levels, dehydration.

Musculoskeletal- Leg cramps, muscle/joint pain, tendon rupture, back/neck pain.

Respiratory - Difficulty in breathing, inflammation of pharynx, sinuses, bronchi, runny nose, asthma, bronchitis, hiccup, nose bleed, lung swelling, pleural effusion, pneumonia, voice alteration.

Skin- Rash, dry skin, inflammation of skin, fungal infection, itching, skin discoloration, skin ulcer, sweating.

Genitourinary- Urinary incontinence, urgency or increased frequency.

Eye and ENT- Abnormal vision, deafness, loss of taste or abnormal taste sensation, ringing in the ear.

Other Precautions : * Patient may develop with increased risk of melanoma (skin cancer), kidney impairment, exacerbate preexisting movement disorder.

Drug Name : Selegiline

Selegiline(Emsam) generic is a selective and irreversible monoamine oxidase inhibitor (MAOI), prescribed for Parkinsonís disease either alone or with levodopa as an adjuvant. It prevents the breakdown of dopamine in the brain, thus improving the symptoms of Parkinsonís disease.
More Info about Selegiline

Trade Names for Selegiline

India : 

International : 

Emsam, Eldepryl, Zelapar
Advertisement



Recommended Reading
Drugs A - Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs Search


    Advertisement
    Drug Price
    Jumex

    Torrent Laboratories Pvt. Ltd.
    Jumex

    Sanofi Synthelabo India Ltd
    Eldepryl (10 mg)

    Themis Medicare Ltd.
    Elegelin

    Sun Pharmaceuticals Industries Ltd.
    Selgin

    Intas Pharmaceutical Ltd.
    Selerin

    Cipla Limited (Protec)
    Selerin -5

    Cipla Limited (Protec)
    Jumax

    Torrent Pharmaceuticals Ltd.
    Jumex (5mg)

    Sanofi Aventis Pharma India
    Eldepryl

    Themis Medicare Ltd.
    What's New on Medindia
    Top 10 Vitamin B12 Foods for Vegetarians - Slideshow
    Targeted Screening Program Beneficial for Prostate Cancer Screening
    Are Menopause Symptoms Troubling You?: Try these Options
    View all

    Medindia Newsletters Subscribe to our Free Newsletters!
    Terms & Conditions and Privacy Policy.

    Most Popular on Medindia

    Drug - Food Interactions Loram (2 mg) (Lorazepam) Post-Nasal Drip Vent Forte (Theophylline) Indian Medical Journals Color Blindness Calculator Iron Intake Calculator Blood Pressure Calculator Drug Interaction Checker Sinopril (2mg) (Lacidipine)

    Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

    © All Rights Reserved 1997 - 2022

    This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use